PMC:7402624 / 9116-10037
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T43 | 904-913 | Body_part | denotes | leukocyte | http://purl.org/sig/ont/fma/fma62852 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
270 | 456-460 | Gene | denotes | IL-6 | Gene:3569 |
271 | 750-758 | Species | denotes | patients | Tax:9606 |
272 | 871-879 | Species | denotes | patients | Tax:9606 |
273 | 179-187 | Disease | denotes | COVID-19 | MESH:C000657245 |
274 | 570-579 | Disease | denotes | mortality | MESH:D003643 |
275 | 678-690 | Disease | denotes | inflammation | MESH:D007249 |
276 | 741-749 | Disease | denotes | COVID-19 | MESH:C000657245 |
277 | 850-862 | Disease | denotes | inflammation | MESH:D007249 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T70 | 179-187 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T71 | 678-690 | Disease | denotes | inflammation | http://purl.obolibrary.org/obo/MONDO_0021166 |
T72 | 741-749 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T73 | 850-862 | Disease | denotes | inflammation | http://purl.obolibrary.org/obo/MONDO_0021166 |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T29 | 456-458 | Chemical | denotes | IL | http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T25 | 678-690 | http://purl.obolibrary.org/obo/GO_0006954 | denotes | inflammation |
T26 | 850-862 | http://purl.obolibrary.org/obo/GO_0006954 | denotes | inflammation |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T64 | 0-124 | Sentence | denotes | To examine potential associations between these clinical features, we performed correlation analysis (Fig. 1C and fig. S1C). |
T65 | 125-358 | Sentence | denotes | This analysis revealed correlations between different COVID-19 disease severity metrics, as well as clinical features or interventions associated with more severe disease (e.g., D-dimer, vasoactive medication) (Fig. 1C and fig. S1C). |
T66 | 359-491 | Sentence | denotes | WBC and PMN also correlated with metrics of disease severity (e.g., APACHE III), as well as with IL-6 levels (Fig. 1C and fig. S1C). |
T67 | 492-734 | Sentence | denotes | Other relationships were also apparent, including correlations between age or mortality and metrics of disease severity and many other correlations between clinical measures of disease, inflammation, and co-morbidities (Fig. 1C and fig. S1C). |
T68 | 735-921 | Sentence | denotes | Thus, COVID-19 patients presented with varied pre-existing comorbidities, complex clinical phenotypes, evidence of inflammation in many patients, and clinically altered leukocyte counts. |